﻿<?xml version="1.0" encoding="utf-8"?>
<Item xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Slug>hepatitis-a-typhoid-vaccine-patient-group-direction-update</Slug>
  <Title>Hepatitis A/Typhoid vaccine: patient group direction (update)</Title>
  <UpdatedAt>2022-02-22T16:13:40.276Z</UpdatedAt>
  <Source>
    <Title>UK Health Security Agency</Title>
  </Source>
  <Specialities>
    <Speciality>
      <Title>Infection and infectious diseases</Title>
      <Key>f48a5fc4-8228-47ec-ba84-e6c8e22ded59</Key>
    </Speciality>
    <Speciality>
      <Title>Vaccination</Title>
      <Key>5a1195de-2f22-4ac5-8ccc-b5b3d292da87</Key>
    </Speciality>
    <Speciality>
      <Title>Liver disorders</Title>
      <Key>e7c0f8c0-3fea-47ed-a4c2-6f1084b3d2b4</Key>
    </Speciality>
  </Specialities>
  <EvidenceType>
    <Title>Other evidence - Drug/medicines management</Title>
    <Key>mas_evidence_types:Drug%2Fmedicines%20management</Key>
    <BroaderTitle>Other evidence</BroaderTitle>
  </EvidenceType>
  <ShortSummary>This updated PGD template supports administration of HepA/Typhoid vaccine to individuals considered at risk of exposure to Salmonella enterica serovar typhi, (S. typhi) and hepatitis A virus, in accordance with recommendations from the National Travel Health Network and Centre.</ShortSummary>
  <Comment>&lt;p&gt;The PGD has been amended to update references and to include minor rewording, layout and formatting changes for clarity and consistency with other UKHSA PGDs.&lt;/p&gt;</Comment>
  <CommentUrl>https://www.medicinesresources.nhs.uk/hepatitis-a-typhoid-vaccine-patient-group-direction-update.html</CommentUrl>
  <ResourceLinks />
  <Url>https://www.gov.uk/government/publications/hepatitis-atyphoid-vaccine-patient-group-direction</Url>
  <PublicationDate>2022-02-21T00:00:00Z</PublicationDate>
  <CreatedAt>2022-02-22T16:12:34.296Z</CreatedAt>
</Item>